Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 12-Sep-24 8:20 PM View:  | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 12-Sep-24 | Sale | 126,301 | $1.71 | $215,836.00 | (6%) 2.12M to 1.99M | |
| 12-Sep-24 8:20 PM View: | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 11-Sep-24 | Sale | 32,600 | $1.71 | $55,879.70 | (2%) 2.15M to 2.12M | |
| 10-Sep-24 7:11 PM View: | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 10-Sep-24 | Sale | 25,500 | $1.77 | $45,109.50 | (1%) 2.17M to 2.15M | |
| 10-Sep-24 7:11 PM View: | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 09-Sep-24 | Sale | 36,492 | $1.89 | $69,141.40 | (2%) 2.21M to 2.17M | |
| 30-Aug-24 4:05 PM View: | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 28-Aug-24 | Gift | 8,563 | -- | -- | (< 1%) 944.06K to 935.5K | |
| 18-Jul-24 4:05 PM View: | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 16-Jul-24 | Sale | 11,396 | $2.44 | $27,827.90 | (< 1%) 2.22M to 2.21M | |
| 11-Jul-24 7:56 PM View: | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 11-Jul-24 | Sale | 47,993 | $2.40 | $115,346.00 | (2%) 2.27M to 2.22M | |
| 11-Jul-24 7:56 PM View: | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 10-Jul-24 | Sale | 18,061 | $2.31 | $41,684.80 | (< 1%) 2.29M to 2.27M | |
| 11-Jul-24 7:56 PM View: | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 09-Jul-24 | Sale | 8,497 | $2.21 | $18,810.70 | (< 1%) 2.3M to 2.29M | |
| 03-Jul-24 2:00 PM View: | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 01-Jul-24 | Sale | 8,288 | $2.12 | $17,597.90 | (< 1%) 2.31M to 2.3M | |
| 28-Jun-24 6:45 PM View: | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 28-Jun-24 | Sale | 17,994 | $2.07 | $37,334.00 | (< 1%) 2.32M to 2.3M | |
| 28-Jun-24 6:45 PM View: | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 27-Jun-24 | Sale | 46,574 | $2.26 | $105,169.00 | (2%) 2.37M to 2.32M | |
| 27-Jun-24 4:05 PM View: | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 25-Jun-24 | Sale | 12,725 | $2.26 | $28,734.30 | (< 1%) 2.38M to 2.37M | |
| 31-May-24 4:05 PM View: | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 31-May-24 | Sale | 5,824 | $2.90 | $16,894.80 | (5%) 114.52K to 108.7K | |
| 31-May-24 4:05 PM View: | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 30-May-24 | Sale | 9,230 | $2.94 | $27,113.10 | (7%) 123.75K to 114.52K | |
| 23-May-24 10:00 PM View: | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 22-May-24 | Sale | 9,800 | $3.02 | $29,596.30 | (< 1%) 2.42M to 2.41M | |
| 23-May-24 10:00 PM View: | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 21-May-24 | Sale | 33,000 | $3.06 | $100,838.00 | (1%) 2.44M to 2.41M | |
| 17-May-24 7:48 PM View: | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 17-May-24 | Sale | 70,885 | $3.25 | $230,326.00 | (3%) 2.51M to 2.44M | |
| 10-May-24 6:57 PM View: | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 10-May-24 | Sale | 151,700 | $3.11 | $472,424.00 | (6%) 2.53M to 2.38M | |
| 10-May-24 6:57 PM View: | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 09-May-24 | Sale | 30,600 | $3.09 | $94,526.50 | (1%) 2.56M to 2.53M | |
| 23-Jan-24 4:05 PM View: | Bandari Jathin Chief Medical Officer | Protara Therapeutics, Inc. (TARA) | 19-Jan-24 | Payment of Exercise | 2,879 | $1.91 | $5,498.89 | (5%) 59.58K to 56.7K | |
| 23-Jan-24 4:05 PM View: | Bandari Jathin Chief Medical Officer | Protara Therapeutics, Inc. (TARA) | 19-Jan-24 | Grant | 23,000 | -- | -- | 63% 36.58K to 59.58K | |
| 23-Jan-24 4:05 PM View: | Fry Hannah VP, Controller | Protara Therapeutics, Inc. (TARA) | 19-Jan-24 | Payment of Exercise | 904 | $1.91 | $1,726.64 | (3%) 30.74K to 29.84K | |
| 23-Jan-24 4:05 PM View: | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 19-Jan-24 | Grant | 59,000 | -- | -- | 7% 892.87K to 951.87K | |
| 23-Jan-24 4:05 PM View: | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 19-Jan-24 | Payment of Exercise | 7,803 | $1.91 | $14,903.70 | (< 1%) 951.87K to 944.06K | |
| 23-Jan-24 4:05 PM View: | Fry Hannah VP, Controller | Protara Therapeutics, Inc. (TARA) | 19-Jan-24 | Grant | 8,000 | -- | -- | 35% 22.74K to 30.74K | |
| 23-Jan-24 4:05 PM View: | Fabbio Patrick Chief Financial Officer | Protara Therapeutics, Inc. (TARA) | 19-Jan-24 | Grant | 22,000 | -- | -- | 100% 0 to 22.0K | |
| 23-Jan-24 4:05 PM View: | Zummo Jacqueline Chf Scientific Operations Off | Protara Therapeutics, Inc. (TARA) | 19-Jan-24 | Grant | 23,000 | -- | -- | 27% 84.34K to 107.34K | |
| 23-Jan-24 4:05 PM View: | Zummo Jacqueline Chf Scientific Operations Off | Protara Therapeutics, Inc. (TARA) | 19-Jan-24 | Payment of Exercise | 3,049 | $1.91 | $5,823.59 | (3%) 107.34K to 104.3K | |
| 12-Jan-24 4:05 PM View: | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 10-Jan-24 | Payment of Exercise | 5,746 | $2.39 | $13,732.90 | (< 1%) 898.61K to 892.87K | |
| 12-Jan-24 4:05 PM View: | Zummo Jacqueline Chf Scientific Operations Off | Protara Therapeutics, Inc. (TARA) | 10-Jan-24 | Payment of Exercise | 5,229 | $2.39 | $12,497.30 | (6%) 89.57K to 84.34K | |
| 12-Jan-24 4:05 PM View: | Bandari Jathin Chief Medical Officer | Protara Therapeutics, Inc. (TARA) | 10-Jan-24 | Payment of Exercise | 1,877 | $2.39 | $4,486.03 | (5%) 38.46K to 36.58K | |
| 05-Jan-24 4:05 PM View: | Fry Hannah VP, Controller | Protara Therapeutics, Inc. (TARA) | 03-Jan-24 | Payment of Exercise | 324 | $2.17 | $703.08 | (1%) 23.06K to 22.74K | |
| 05-Jan-24 4:35 PM View: | Zummo Jacqueline Chf Scientific Operations Off | Protara Therapeutics, Inc. (TARA) | 03-Jan-24 | Payment of Exercise | 1,899 | $2.17 | $4,120.83 | (2%) 91.47K to 89.57K | |
| 05-Jan-24 4:30 PM View: | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 03-Jan-24 | Payment of Exercise | 5,840 | $2.17 | $12,672.80 | (< 1%) 904.45K to 898.61K | |
| 18-Jul-23 4:05 PM View: | Fry Hannah VP, Controller | Protara Therapeutics, Inc. (TARA) | 17-Jul-23 | Payment of Exercise | 10,075 | $2.56 | $25,792.00 | (30%) 33.14K to 23.06K | |
| 05-Jul-23 10:00 PM View: | Bandari Jathin Chief Medical Officer | Protara Therapeutics, Inc. (TARA) | 03-Jul-23 | Payment of Exercise | 682 | $2.46 | $1,677.72 | (2%) 39.14K to 38.46K | |
| 27-Jun-23 7:26 PM View: | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 27-Jun-23 | Gift | 7,420 | -- | -- | (< 1%) 911.87K to 904.45K | |
| 27-Jun-23 7:26 PM View: | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 23-Jun-23 | Gift | 1,890 | -- | -- | (< 1%) 913.76K to 911.87K | |
| 20-Jan-23 4:00 PM View: | Bandari Jathin Chief Medical Officer | Protara Therapeutics, Inc. (TARA) | 19-Jan-23 | Grant | 20,700 | -- | -- | 112% 18.44K to 39.14K | |
| 20-Jan-23 4:00 PM View: | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 19-Jan-23 | Grant | 51,300 | -- | -- | 6% 866.98K to 918.28K | |
| 20-Jan-23 4:00 PM View: | Fry Hannah VP, Controller | Protara Therapeutics, Inc. (TARA) | 19-Jan-23 | Grant | 5,900 | -- | -- | 22% 27.24K to 33.14K | |
| 20-Jan-23 4:00 PM View: | Zummo Jacqueline Chf Scientific Operations Off | Protara Therapeutics, Inc. (TARA) | 19-Jan-23 | Grant | 19,900 | -- | -- | 28% 71.57K to 91.47K | |
| 11-Jan-23 4:03 PM View: | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 10-Jan-23 | Payment of Exercise | 5,855 | $3.00 | $17,565.00 | (< 1%) 872.84K to 866.98K | |
| 11-Jan-23 4:05 PM View: | Zummo Jacqueline Chf Scientific Operations Off | Protara Therapeutics, Inc. (TARA) | 10-Jan-23 | Payment of Exercise | 5,225 | $3.00 | $15,675.00 | (7%) 76.8K to 71.57K | |
| 11-Jan-23 4:02 PM View: | Bandari Jathin Chief Medical Officer | Protara Therapeutics, Inc. (TARA) | 10-Jan-23 | Payment of Exercise | 1,876 | $3.00 | $5,628.00 | (9%) 20.32K to 18.44K | |
| 04-Jan-23 4:24 PM View: | Fry Hannah VP, Controller | Protara Therapeutics, Inc. (TARA) | 03-Jan-23 | Payment of Exercise | 361 | $2.80 | $1,010.80 | (1%) 27.6K to 27.24K | |
| 04-Jan-23 4:26 PM View: | Zummo Jacqueline Chf Scientific Operations Off | Protara Therapeutics, Inc. (TARA) | 03-Jan-23 | Payment of Exercise | 2,159 | $2.80 | $6,045.20 | (3%) 78.96K to 76.8K | |
| 04-Jan-23 4:25 PM View: | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 03-Jan-23 | Payment of Exercise | 6,604 | $2.80 | $18,491.20 | (< 1%) 879.44K to 872.84K | |
| 30-Dec-22 6:00 PM View: | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 30-Dec-22 | Private Sale | 15,473 | $2.71 | $41,948.90 | < 1% 2.68M to 2.69M |
